TY - JOUR
T1 - Reevaluation of definition, screening, and diagnostic criteria of gestational diabetes mellitus in Japan
AU - Toyoda, Nagayasu
AU - Sugiyama, Takashi
AU - Sameshima, Hiroshi
AU - Hiramatsu, Yuji
AU - Mitao, Ken
AU - Yasuhi, Ichiro
AU - Waguri, Masako
AU - Sanaka, Mayumi
AU - Anazawa, Sonoko
AU - Ito, Chikako
AU - Origasa, Hideki
AU - Iwamoto, Yasuhiko
AU - Kawamori, Ryuzo
PY - 2008
Y1 - 2008
N2 - Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset or first recognition during pregnancy. Some 3% of all pregnant women with GDM cies are diagnosed annually in Japan. Exposure to maternal hyperglycemia during pregnancy is associated with birth defects and perinatal complications and other adverse effects on childhood growth and glucose regulation, necessitating adequate GDM screening and diagnosis. A lack of international consensus remains on the screening, diagnosis, treatment, and follow-up of GDM among panels including the American Diabetes Association (ADA), World Health Organization (WHO), and the American College of Obstetricians and Gynecologists (ACOG). This lack of agreement continues to cause confusion about the ideal clinical approach to GDM. The committee of the Japan Diabetes Society has therefore evaluated the definition, screening, and diagnostic criteria of GDM in Japan. We must reevaluate them again after establishment of hyperglycemia and pregnancy adverse outcome (HAPO) studies.
AB - Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset or first recognition during pregnancy. Some 3% of all pregnant women with GDM cies are diagnosed annually in Japan. Exposure to maternal hyperglycemia during pregnancy is associated with birth defects and perinatal complications and other adverse effects on childhood growth and glucose regulation, necessitating adequate GDM screening and diagnosis. A lack of international consensus remains on the screening, diagnosis, treatment, and follow-up of GDM among panels including the American Diabetes Association (ADA), World Health Organization (WHO), and the American College of Obstetricians and Gynecologists (ACOG). This lack of agreement continues to cause confusion about the ideal clinical approach to GDM. The committee of the Japan Diabetes Society has therefore evaluated the definition, screening, and diagnostic criteria of GDM in Japan. We must reevaluate them again after establishment of hyperglycemia and pregnancy adverse outcome (HAPO) studies.
UR - http://www.scopus.com/inward/record.url?scp=84873146697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873146697&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84873146697
SN - 0021-437X
VL - 51
SP - 939
EP - 947
JO - Journal of the Japan Diabetes Society
JF - Journal of the Japan Diabetes Society
IS - 10
ER -